a public good project by the
Synthesis
Company
of California

© 2026

Meifang He | doi.page

0 works0 citations0 h-index

Meifang He

Sun Yat-sen University(CN)The First Affiliated Hospital, Sun Yat-sen University(CN)Taiyuan Central Hospital(CN)

Publications by Year

Research Areas

Phagocytosis and Immune Regulation, Pancreatic and Hepatic Oncology Research, Cancer Cells and Metastasis, Pancreatic function and diabetes, Immunotherapy and Immune Responses

Most-Cited Works

→ SARS-CoV-2 spike protein dictates syncytium-mediated lymphocyte elimination(2021)167 cited
→ 3D printed biodegradable implants as an individualized drug delivery system for local chemotherapy of osteosarcoma(2019)127 cited
→ Cell-in-Cell Death Is Not Restricted by Caspase-3 Deficiency in MCF-7 Cells(2016)68 cited
→ Detecting cell-in-cell structures in human tumor samples by E-cadherin/CD68/CD45 triple staining(2015)58 cited
→ Cordycepin Reverses Cisplatin Resistance in Non-small Cell Lung Cancer by Activating AMPK and Inhibiting AKT Signaling Pathway(2021)52 cited
→ In-cell infection: a novel pathway for Epstein-Barr virus infection mediated by cell-in-cell structures(2015)41 cited

→ Identification and validation of heterotypic cell-in-cell structure as an adverse prognostic predictor for young patients of resectable pancreatic ductal adenocarcinoma(2020)

41 cited

→ Prevalence of Heterotypic Tumor/Immune Cell-In-Cell Structure In Vitro and In Vivo Leading to Formation of Aneuploidy(2013)41 cited

→ Inactivation of oncogenic cAMP-specific phosphodiesterase 4D by miR-139-5p in response to p53 activation(2016)37 cited

→ Upregulation of macrophage migration inhibitory factor promotes tumor metastasis and correlates with poor prognosis of pancreatic ductal adenocarcinoma(2018)35 cited